Valneva SE American Depositary Shares (VALN) Stock Price

VALNStock

$6.43−26.96%52W

Market Cap$609.71M

P/E—

PEG Ratio—

Div yield—

Beta1.94

VALN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-54.45%

Price vs S&P 500 (4W)26.42%

VGM Score51.61

Book Value / Share (Quarterly)$0.71

P/TBV (Annual)7.66x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-21.52%

Cash Flow / Share (Quarterly)$-0.38

Price vs S&P 500 (YTD)-36.25%

Gross Margin (TTM)23.83%

Net Profit Margin (TTM)-48.58%

EPS (TTM)$-1.26

10-Day Avg Trading Volume1.17M

EPS Excl Extra (TTM)$-1.26

Revenue Growth (5Y)9.62%

EPS (Annual)$-0.79

ROI (Annual)-36.75%

Gross Margin (Annual)38.66%

Net Profit Margin (5Y Avg)-39.98%

Cash / Share (Quarterly)$0.73

Revenue Growth QoQ (YoY)-37.23%

ROA (Last FY)-28.88%

Revenue Growth TTM (YoY)14.56%

EBITD / Share (TTM)$-0.74

ROE (5Y Avg)-60.52%

Operating Margin (TTM)-34.88%

Cash Flow / Share (Annual)$-0.38

P/B Ratio4.40x

P/B Ratio (Quarterly)6.05x

Net Income / Employee (Annual)$-192,510

EV / Revenue (TTM)1.76x

Net Interest Coverage (TTM)-2.56x

ROA (TTM)-37.47%

EV / EBITDA (TTM)22.42x

EPS Incl Extra (Annual)$-0.79

Current Ratio (Annual)2.38x

Quick Ratio (Quarterly)1.85x

3-Month Avg Trading Volume0.84M

52-Week Price Return-26.96%

Revenue / Employee (TTM)$506,555

Tangible BV / Share (Quarterly)$0.56

P/S Ratio (Annual)2.68x

Asset Turnover (Annual)0.44x

52-Week High$6.19

Operating Margin (5Y Avg)-28.31%

EPS Excl Extra (Annual)$-0.79

CapEx CAGR (5Y)-25.46%

Tangible BV CAGR (5Y)14.81%

26-Week Price Return-42.52%

Quick Ratio (Annual)1.85x

13-Week Price Return11.53%

Total Debt / Equity (Annual)1.95x

Current Ratio (Quarterly)2.38x

Enterprise Value$655.26M

Revenue / Share Growth (5Y)-3.10%

Asset Turnover (TTM)0.71x

Book Value / Share Growth (5Y)-6.39%

Revenue / Employee (Annual)$291,895

Inventory Turnover (Annual)2.06x

Pretax Margin (Annual)-65.34%

Cash / Share (Annual)$0.73

3-Month Return Std Dev55.90%

Gross Margin (5Y Avg)34.55%

Net Income / Employee (TTM)$-320,192

EBITDA CAGR (5Y)41.51%

ROE (Last FY)-108.50%

Net Interest Coverage (Annual)-3.10x

EPS Basic Excl Extra (Annual)$-0.79

P/FCF (TTM)33.39x

Receivables Turnover (TTM)10.20x

Total Debt / Equity (Quarterly)1.95x

EPS Incl Extra (TTM)$-1.26

Receivables Turnover (Annual)5.54x

ROI (TTM)-47.24%

P/S Ratio (TTM)1.54x

Pretax Margin (5Y Avg)-39.29%

Revenue / Share (Annual)$1.20

Tangible BV / Share (Annual)$0.56

Price vs S&P 500 (52W)-45.52%

Year-to-Date Return-24.80%

5-Day Price Return-2.68%

EPS Normalized (Annual)$-0.79

ROA (5Y Avg)-17.08%

Net Profit Margin (Annual)-65.95%

Month-to-Date Return30.17%

Cash Flow / Share (TTM)$-0.23

EBITD / Share (Annual)$-0.53

Operating Margin (Annual)-46.98%

LT Debt / Equity (Annual)1.52x

ROI (5Y Avg)-26.83%

LT Debt / Equity (Quarterly)1.52x

EPS Basic Excl Extra (TTM)$-1.26

P/TBV (Quarterly)7.66x

P/B Ratio (Annual)6.05x

Inventory Turnover (TTM)2.97x

Pretax Margin (TTM)-47.95%

Book Value / Share (Annual)$0.71

Price vs S&P 500 (13W)9.57%

Beta1.94x

P/FCF (Annual)3.95x

Revenue / Share (TTM)$1.97

ROE (TTM)-109.23%

52-Week Low$2.36

vGradeC

gGradeC

mGradeC

vgmGradeC

VALN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.09	-$0.46	-395.44%(-$0.37)
Q1 2026	May 13, 2026	-$0.24	-$0.49	-100.74%(-$0.24)
Q4 2025	Mar 17, 2026	—	-$0.76	—
Q3 2025	Nov 20, 2025	-$0.30	-$0.70	-130.73%(-$0.39)
Q2 2025	Aug 12, 2025	-$0.22	-$0.19	+15.45%(+$0.03)

VALN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.08

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
VALNValneva SE American Depositary Shares	C	C	C	$6.43
AMGNAmgen Inc	C	C	B	$432.42
GILDGilead Sciences Inc	C	B	B	$145.68
ARGXargenx SE American Depositary Shares	D	A	B	$1023.21
MRNAModerna, Inc. Common Stock	D	C	A	$137.99
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$207.88
BIIBBiogen Inc. Common Stock	C	D	B	$218.50
BNTXBioNTech SE American Depositary Share	C	C	C	$102.08
NBIXNeurocrine Biosciences Inc	C	B	C	$154.06
EXELExelixis Inc	C	B	B	$54.45
HALOHalozyme Therapeutics, Inc.	C	B	B	$105.35
TECHBio-Techne Corp.	D	C	B	$72.35
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$351.46
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.97
RGENRepligen Corp	D	C	B	$176.27
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$118.15
PCVXVaxcyte, Inc. Common Stock	—	—	B	$59.84
QGENQIAGEN N.V.	C	C	B	$43.11
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$141.38
IBRXImmunityBio, Inc. Common Stock	F	A	B	$8.05
IMVTImmunovant, Inc. Common Stock	—	—	B	$41.20
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$57.80
CGONCG Oncology, Inc. Common stock	F	A	B	$74.34
CRSPCRISPR Therapeutics AG	D	B	C	$57.72
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	$18.77
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$25.19
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.00
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.01
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.76
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$29.32
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.82
KODKodiak Sciences Inc Common Stock	—	—	B	$37.72
MESOMesoblast Limited American Depositary Shares	D	B	B	$17.44
VCELVericel Corporation	D	B	B	$40.95
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$44.84
ADMAADMA Biologics, Inc.	C	C	C	$9.34
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$36.62
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$5.77
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.83
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	$123.41
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.34
ALVOAlvotech Ordinary Shares	C	D	C	$4.95
NVAXNovavax Inc	B	D	C	$9.26
MAZEMaze Therapeutics, Inc. Common Stock	—	—	C	$27.44
SLBTSL Science Holding Limited Ordinary Shares	—	—	C	$2.70
REPLReplimune Group, Inc.	—	—	A	$15.50
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.45
VORVor Biopharma Inc. Common Stock	—	—	B	$22.65
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$21.70
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	B	$13.82
SANASana Biotechnology, Inc. Common Stock	—	—	B	$3.93

About Valneva SE American Depositary Shares

Valneva SE is a vaccine company with marketed products for travelers, including IXIARO, DUKORAL, and IXCHIQ. The company generates revenue primarily from vaccine sales while maintaining development programs for new vaccine candidates and COVID-19 vaccine initiatives. Additional revenue streams include technology licensing and manufacturing services.